20
Participants
Start Date
February 12, 2024
Primary Completion Date
August 1, 2024
Study Completion Date
August 1, 2024
Pramlintide
At time 0 min, continuous infusion of a stable amylin analogue (pramlintide) will be initiated at a rate of 3.0 pmol/kg/min. The infusion will be terminated after 180 minutes.
Placebo (saline) infusion
At time 0 min, continuous infusion of isotonic saline will be initiated at a rate of 150 ml/h. The infusion will be terminated after 180 minutes.
RECRUITING
Center for Clinical Metabolic Research, Gentofte Hospital, Hellerup
Filip Krag Knop
OTHER